01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 23.18
+4.32%Forward multiples
Based on analyst estimates
- P/E forward
- 23.14x
- P/E 2026E
- 10.24x
- P/E 2027E
- 9.38x
- P/E 2028E
- 8.40x
- P/S forward
- 3.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.26x
- PEG TTM
- 2.55x
- Price / book
- 1.34x
- Price / sales
- 1.72x
- Price / cash flow
- 5.46x
Enterprise value
- Enterprise value
- HKD 18.2B
- EV / sales
- 1.52x
- EV / EBITDA
- 6.33x
- EV / EBIT
- 7.44x
- Market cap
- HKD 20.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026